| First Author | Han SY | Year | 2004 |
| Journal | Oncogene | Volume | 23 |
| Issue | 22 | Pages | 3990-8 |
| PubMed ID | 15007387 | Mgi Jnum | J:90858 |
| Mgi Id | MGI:3044875 | Doi | 10.1038/sj.onc.1207526 |
| Citation | Han SY, et al. (2004) CpG methylation in the Fhit regulatory region: relation to Fhit expression in murine tumors. Oncogene 23(22):3990-8 |
| abstractText | To determine if: (1) 5' CpG island methylation is related to Fhit inactivation; (2) there are tumor or carcinogen-specific methylation patterns, we examined 35 CpG sites in the promoter, exon and intron 1 of the mouse Fhit gene. In primary tumors of lung, urinary bladder and tongue, induced by different carcinogens, 15-35% of sites were methylated, with specific methylation patterns associated with each cancer type, suggesting cancer- or tissue-specific methylation patterns. The methylation patterns were associated with reduced Fhit expression, as determined by immunohistochemical analyses. Methylation of rat Fhit 5' CpGs in mammary adenocarcinomas, detected by methylation specific PCR amplification, also correlated with reduced gene expression. Thus, there was an overall association between promoter/exon 1 methylation and decreased Fhit expression. In contrast, in cancer-derived cell lines 70-95% of the CpG sites were methylated. This is the first detailed study of the relationship between Fhit 5' CpG island methylation and Fhit expression in murine tumors, our main models for preclinical cancer studies, and provides evidence that loss of Fhit expression and methylation are correlated in these mouse models and these models will be useful to examine the complex relationships among gene expression, methylation patterns and organ specificity. |
